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Abstract
The signaling pathways orchestrating both the evolution and development of language in the 
human brain remain unknown. To date, the transcription factor FOXP2 (forkhead box P2) is the 
only gene implicated in Mendelian forms of human speech and language dysfunction1,2,3. It has 
been proposed, that the amino acid composition in the human variant of FOXP2 has undergone 
accelerated evolution, and this change occurred around the time of language emergence in 
humans4,5. However, this remains controversial, and whether the acquisition of these amino acids 
in human FOXP2 has any functional consequence in human neurons remains untested. Here, we 
demonstrate that these two amino acids alter FOXP2 function by conferring differential 
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transcriptional regulation in vitro. We extend these observations in vivo to human and chimpanzee 
brain, and use network analysis to identify novel relationships among the differentially expressed 
genes. These data provide experimental support for the functional relevance of changes in FOXP2 
that occur on the human lineage, highlighting specific pathways with direct consequences for 
human brain development and disease. Since FOXP2 has an important role in speech and language 
in humans, the identified targets may have a critical function in the development and evolution of 
language circuitry in humans.
The amino acid structure of FOXP2 had been highly conserved along the mammalian 
lineage until the common ancestor of humans and chimpanzees, when the human variant of 
FOXP2 acquired two different amino acids under positive selection, which has been 
interpreted as evidence for accelerated evolution4,5. To test whether the amino acids under 
positive selection in human FOXP2 have a distinct biological function, which would support 
the role of these changes in evolution, we expressed either human FOXP2 or the same 
construct mutated at two sites to yield the chimpanzee amino acid content, FOXP2chimp, in 
human neuronal cells without endogenous FOXP2 (Fig. 1a–f). Exogenous FOXP2 protein 
expressed from both constructs was localized in the nucleus as determined by 
immunocytochemistry (Fig. 1c–e) and subcellular fractionation (Fig. 1f), consistent with its 
endogenous expression. To determine if modifying two amino acids leads to changes in 
gene expression, we conducted whole genome microarray analysis. We identified 61 genes 
significantly upregulated and 55 genes downregulated by FOXP2 compared to FOXP2chimp 
(Supplementary Table 1), as well as genes regulated by both FOXP2 and FOXP2chimp 
(Supplementary Table 2). Interestingly, FOXP2chimp overexpression resulted in more 
changes in gene regulation than FOXP2 (Supplementary Table 3). In replicate experiments 
in a different human neuronal cell line, FOXP2chimp again regulated more genes than 
FOXP2 even though its expression was higher than FOXP2 in these cells (data not shown). 
To control for any potential confounding effects of FOXP2 levels, we performed 
correlations of the levels of every gene on the array to either FOXP2 or FOXP2chimp levels, 
as well as performed random permutation testing, and found no significant differences 
between other genes’ correlations to either FOXP2 or FOXP2chimp. These data indicate that 
the differentially expressed genes are not due to different levels of FOXP2 or FOXP2chimp, 
and are a true indication of differential transcriptional regulation by these two proteins.
To confirm the validity of differentially expressed FOXP2 target genes, we conducted qRT-
PCR using independent RNA samples. We confirmed 93% of the FOXP2 upregulated genes 
and 75% of the downregulated genes examined (Fig. 1g–h and Supplementary Figure 1). 
Five genes confirmed by qRT-PCR (COL9A1, ROR2, SLIT1, SYK, and TAGLN; Fig. 1g–h 
and Supplementary Figure 1) were previously identified as direct FOXP2 targets using 
ChIP-chip6,7. Sixty percent of promoters of the identified differentially expressed genes 
have at least one canonical FOXP2 binding site, 92% have at least one forkhead domain 
binding site, and 99% have at least one “core” FOXP2 binding site (Supplementary Table 
4). The canonical FOXP2 binding site CAAATT, as well as the core site AAAT, is 
significantly enriched in the downregulated genes (P=3.3e-04 and P=8.6e-03, respectively) 
compared to randomly permuting the same number of promoters from the genome. Genes 
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with promoters containing a canonical FOXP2 binding site are likely to be direct FOXP2 or 
FOXP2chimp targets.
To confirm that these findings were not an artifact of the cell lines used, we further assessed 
whether a different primary neural cell, human neural progenitors (NHNPs), would exhibit 
similar differential regulation by FOXP2 and FOXP2chimp. We confirmed one-third of the 
genes examined in these human cells using both a different method of gene transduction, 
and populations of cells with greater levels of FOXP2chimp compared to human FOXP2 
over-expression, which complements the SH-SY5Y data to further show that the observed 
relationships are not due to FOXP2 levels (Supplementary Figure 2). As an additional level 
of validation and to extend the findings to the level of protein, we confirmed two genes, 
CACNB2 and ENPP2, by immunoblotting in additional SH-SY5Y cell lines (Supplementary 
Figure 3).
To explore the potential function of the differential FOXP2 targets, we determined 
enrichment of gene ontology (GO) categories. GO categories enriched for genes upregulated 
by FOXP2 compared to FOXP2chimp are involved in transcriptional regulation of gene 
expression and cell-cell signaling. Those GO categories enriched for genes downregulated 
by FOXP2 compared to FOXP2chimp are important for protein and cell regulation 
(Supplementary Table 5). These data support the idea that FOXP2 and FOXP2chimp have 
distinguishable downstream effects as reflected by their differences in gene regulation.
To determine the potential mechanisms by which FOXP2 or FOXP2chimp might 
differentially regulate gene expression, we first examined whether either protein 
preferentially interacts with FOXP1 or FOXP4, two proteins known to heterodimerize with 
FOXP28. Both FOXP2 and FOXP2chimp co-localized with FOXP1 in the cell nucleus, co-
immunoprecipitated with FOXP1 as evidenced by immunoblotting, and co-
immunoprecipitated with both FOXP1 or FOXP4 when assayed by mass spectrometry (Fig. 
1c–e, 2a–b, and Supplementary Fig. 4b–g), ruling out a major difference in FOXP1 or 
FOXP4 interaction causing differential gene expression. Mass spectrometry showed no 
significant difference in either co-immunoprecipitation experiment, indicating that 
differences in hetero- or homo-dimerization did not underlie the observed differences in 
gene expression between the chimpanzee and human FOXP2. We also tested whether 
changes in cell proliferation could account for gene expression differences, but did not find 
significant changes in growth with either FOXP2 construct (Fig. 2c).
We next assessed whether FOXP2 and FOXP2chimp expression led to differential promoter 
transactivation of target genes. We selected eight genes confirmed by qRT-PCR that also 
contained at least one forkhead binding site (Supplementary Table 6). Six of the promoters 
tested showed differential regulation by FOXP2 compared to FOXP2chimp in the same 
direction as the microarrays (Fig. 2d–e), while two did not demonstrate significant 
transactivation in either direction (data not shown). In contrast, a canonical FOXP2 binding 
site in triplicate alone, outside of a genomic context, was regulated equally by both FOXP2 
and FOXP2chimp (Supplementary Figure 5). Given the complexity of cis-acting gene 
transactivation elements, these data are particularly compelling considering our use of 
simplified 5′ promoter regions. These data demonstrate that at least a subset of differentially 
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regulated genes is also differentially transactivated by FOXP2 and FOXP2chimp, indicating 
they are likely direct FOXP2 targets.
To place these gene expression changes within a more systematic context, we applied 
weighted gene co-expression network analysis9,10 to the entire SH-SY5Y microarray data 
set to examine co-regulation of gene expression across all genes. We uncovered two 
networks where the module eigengene was driven by differences in FOXP2 and 
FOXP2chimp, and one network driven by similar gene regulation (Figure 3 and 
Supplementary Figure 6). Using this unsupervised analysis, we found additional genes of 
interest that do not meet the criteria for differential expression, but that are co-regulated with 
differences in FOXP2 and FOXP2chimp expression (Supplementary Table 7). Strikingly, two 
of the genes with the most connections, so-called “hub” genes, in one of the differential 
networks are DLX5 and SYT4, two genes important for brain development and 
function11,12.
To extrapolate these findings to true in vivo expression and provide external validation, we 
compared the differentially expressed genes in SH-SY5Y cells to differentially expressed 
genes from adult human and chimpanzee brain tissue. We performed microarray analysis on 
tissue from three brain regions where FOXP2 is expressed in developing brain: caudate 
nucleus, frontal pole, and hippocampus. We examined gene expression in human compared 
to chimpanzee for each brain region separately as well as for all brain regions combined, for 
a total of eight comparisons. There was a significant overlap in seven out of eight of these 
comparisons, a remarkable convergence with the in vitro data (Table 1). These data are 
particularly notable, since the tissue was from adult brain. We surmise that a subset of the 
overlapping differentially expressed genes found in adult brain is the result of differential 
functions by FOXP2 in the developing brain, and may lead to increased vulnerability to 
disease. For example, mutations in both FGF14 and PPP2R2B lead to spinocerebellar ataxia 
(SCA27 and SCA12, respectively), which involves motor-related speech defects13,14. Since 
both of these genes play a critical role in cerebellar function, it is of note that patients with 
FOXP2 mutations have decreased gray matter in the cerebellum15, and Foxp2 knockout 
mice have their most pronounced morphological phenotype in the cerebellum16. Mutations 
in COL9A1 lead to Stickler syndrome in which patients have craniofacial abnormalities17, 
and patients with mutations in GJA12 present with ataxia, nystagmus, other motor 
impairments, and often mental retardation18.
While comparisons of developing brain between human and chimpanzees are challenged by 
a lack of tissue, a recent study examined gene expression in many regions of human fetal 
brain19. Comparing the list of 116 differentially expressed genes with those focally 
expressed during human fetal development, we find 14 genes specifically expressed in one 
brain region, including FOXP2 (Supplementary Table 8). Two regions of the human fetal 
brain with high FOXP2 expression19, perisylvian cortex and cerebellum, have a significant 
number of enriched genes that overlap with the differentially expressed FOXP2 and 
FOXP2chimp genes (P=1.1e-04 and P=1.3e-04, respectively; Supplementary Table 8). A 
significant number of the differentially expressed genes are also associated with human-
specific accelerated highly conserved noncoding sequences (haCNS), but not with 
chimpanzee highly conserved noncoding sequences (P=1.2e-06 and P=0.04; Supplementary 
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Table 8)19,20. We confirmed a number of these genes, such as GRM8, MAOB, PPP2R2B, 
PRICKLE1, RUNX1T1 either by qRT-PCR and/or with the adult in vivo dataset (Figure 1 
and Table 1). Together, these data suggest that the FOXP2 differentially expressed genes 
identified here may have important roles in brain development and patterning, and may also 
have evolved cis-regulatory elements important for their expression specifically in human 
brain.
Previously, we identified ChIP-chip targets of FOXP2 that themselves were also under 
positive selection6. We hypothesized that networks of genes important for language 
circuitry had been positively selected through selective pressure on human brain evolution. 
Thus, we also examined whether any differential FOXP2 targets were themselves under 
positive selection. Five genes (AMT, C6orf48, MAGEA10, PHACTR2, and SH3PXD2B) met 
the standard criteria of Ka/Ks ≥ 1.0 for positive selection on the human lineage 
(Supplementary Table 9)21. These data, along with the haCNS and expression data 
mentioned above, suggest that a subset of differential FOXP2 targets may have co-evolved 
to regulate pathways involved in higher cognitive functions.
The positive selection of two amino acids in human FOXP2 was previously hypothesized as 
a mechanism by which human FOXP2 might assume a novel biological function with 
implications for speech and language evolution4,5. A recent study made an elegant attempt 
to examine the role of these two amino acids by generating a transgenic mouse with the 
human version of FOXP222. These mice exhibit a number of interesting phenotypic 
alterations including increases in dendritic length in striatal neurons and changes in 
ultrasonic vocalizations, as well as some modest changes in gene expression. Although the 
mouse is an experimentally tractable model system, from a strictly evolutionary standpoint, 
the interpretation of data obtained in the mouse specifically for the study of human evolution 
is challenged by the vast differences in human and mouse brain and the amount of time 
since the human and mouse common ancestor diverged (70 million years23). Here, we 
demonstrate that these two amino acid changes have a functional consequence in human 
cells, validate these differences in vivo in tissue, and elucidate some of the downstream 
pathways affected by this adaptive evolutionary change.
Using whole genome microarrays, we uncovered genes that are differentially regulated upon 
mutation of these two amino acids, including some with functions critical to the 
development of the human CNS. Moreover, this study reveals enrichment of differential 
FOXP2 targets with known involvement in cerebellar motor function, craniofacial 
formation, and cartilage and connective tissue formation, suggesting an important role for 
human FOXP2 in establishing both the neural circuitry and physical structures needed for 
spoken language. The significant overlap of human FOXP2 targets in cell lines with genes 
enriched in human compared to chimpanzee brain tissue presents the possibility that human 
and chimpanzee FOXP2 have differentially regulated targets during brain development. As 
suggested by King and Wilson over 30 years ago24, and reaffirmed by the sequencing of 
both the human and chimpanzee genomes, the phenotypic differences exhibited by humans 
and chimpanzees cannot be explained by differences in DNA sequence alone, and are likely 
due to differences in gene expression and regulation. Previous microarray studies identified 
differences in gene expression between human and chimpanzee brains25,26. Here, we link 
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new whole genome expression microarray data from human and chimpanzee brain to direct 
differences in gene regulation by the human and chimpanzee version of the transcription 
factor FOXP2. Since normal FOXP2 function is critical for speech in humans, these 
differentially regulated targets may be relevant to the evolution and establishment or 
function of pathways necessary for speech and language in humans.
Methods Summary
Cell Culture and Stable Line Generation
SH-SY5Y cells (ATCC) and human fetal neuronal progenitors (Lonza) were grown 
according to the manufacturer’s instructions, with some modifications (see Methods).
Microarrays
Total RNA was extracted using Qiagen’s RNeasy kit. Illumina HumanRef-8 v2 (SH-SY5Y 
samples) or v3 (tissue samples) were used and analyzed as described27. Sample information 
is in Methods.
Full Methods accompany this paper.
Methods
Antibodies
The following antibodies were either used for immunoblotting (IB) or immunofluorescence 
(IF): anti-FLAG (mouse monoclonal, Sigma; 1:10,000 (IB), 1:10,000 (IF)); anti-GAPDH 
(mouse monoclonal, Chemicon; 1:2500 (IB)); anti-beta-tubulin (rabbit polyclonal, Abcam; 
1:1000 (IB); anti-FOXP1 (6; 1:5000 (IB), 1:1000 (IF); anti-CACNB2 (mouse monoclonal, 
Abcam; 1:100 (IB)); anti-ENPP2 (rabbit polyclonal, Cayman Chemical; 1:400 (IB)); goat 
anti-rabbit horseradish peroxidase (Cell Signaling, 1:2500); goat anti-mouse horseradish 
peroxidase (Chemicon, 1:5000); goat anti-mouse Alexa Fluor 488 (Invitrogen, 1:1500); goat 
anti-rabbit Alexa Fluor 594 (Invitrogen, 1:1500).
Cell Culture and Stable Line Generation
Stable SH-SY5Y cell lines were generated by transfecting cells with pCMV-Tag4a 
expression constructs using FuGENE (Roche Applied Science) according to the 
manufacturer’s instructions. Populations of stable cells were selected using 1mg/ml 
Geneticin (Invitrogen). Multiple independent lines were generated from independent 
transfections. Stable human fetal neuronal progenitors cell lines were generated by 
transducing cells with lentiviruses as previously described28. FOXP2-producing lentiviral 
vectors were generated by replacing the eGFP in pLUGIP (ATCC) with FOXP2.
Immunoprecipitation
Nuclear extract were incubated with either 1 μg of FLAG antibody (Sigma) or a polyclonal 
FOXP1 antibody6.
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Cell Proliferation Assay
Equal numbers of cells (2.0E+04) were plated on time zero and counted every subsequent 
day after trypsinization using a hemacytometer.
Dual luciferase assays
293T cells (ATCC) were transfected with 50ng of reporter construct expressing Photinus 
pyralis (firefly) luciferase, 1ng of Renilla luciferase plasmid (pRL-EF), and 50ng of pCMV-
Tag4a FOXP2 expression plasmid using FuGENE (Roche Applied Science) according to the 
manufacturer’s instructions. Forty-eight hours later, cells were lysed and analyzed using the 
dual luciferase reporter assay system (Promega) according to the manufacturer’s 
instructions. Co-transfection of Renilla was used for transfection normalization, and values 
were additionally normalized to cells transfected with a promoter-less luciferase construct. 
Promoter information is in Supplementary Table 6. The canonical FOXP2 binding site 
driving luciferase was generated by cloning AATTTG in triplicate into pGL4 (Promega).
Gene Ontology Analysis
GO analysis was performed as described6 using DAVID (http://david.abcc.ncifcrf.gov). The 
differentially expressed genes were compared to all of the genes on the microarrays and a P 
value computed using a Fisher’s Exact Test.
Immunoblotting
Whole cell protein lysates were generated and immunoblotted as described28.
Immunofluorescence
Cells were grown on glass coverslips, fixed in 2% paraformaldehyde, and permeabilized in 
0.2% Triton-X. TBST containing 10% milk, and 10% normal goat serum was used as 
blocking solution at room temperature for one hour. Antibodies were diluted in TBS with 
0.25% BSA, 0.25% normal goat serum and 0.1% Triton-X and applied to cells overnight at 
4°C. Secondary antibodies were diluted in blocking solution and added at room temperature 
for one hour. Coverslips were mounted to glass slides and images taken using a Zeiss Axio 
Imager D1.
Mass Spectrometry
FOXP2 immunoprecipitates were precipitated by the addition of trichloroacetic acid and 
proteolyzed by the sequential addition of Lys-C and trypsin proteases29. Digested peptide 
samples were then analyzed by mass spectrometry as described29. Proteins were considered 
to be present in a sample if at least two peptides per protein were identified using a false 
positive rate of less than 5% per peptide as determined using a decoy database strategy30.
Microarrays
For the SH-SY5Y data, we analyzed four biological replicates of each genotype from three 
independently generated cell lines for a total of 12 microarrays per genotype. Each of these 
cell lines was created from populations of cells rather than single clones, and as such, the 
expression data represents changes from hundreds of independent integrations throughout 
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the cells’ genomes. Further, as the endogenous FOXP2 expression is very low in SH-SY5Y 
cells, the potential confound of heterodimerization with endogenous human FOXP2 is 
mitigated in these cells. For the tissue data, we analyzed three to six independent samples for 
each brain region in each species.
Permutation Testing
For FOXP2 correlations, we computed the average correlation for each gene on the 
microarray to either the level of the human or the chimpanzee FOXP2. We then derived the 
absolute difference in correlation for each gene between the human and chimpanzee FOXP2 
arrays. The average of these differences was not statistically different from performing the 
same test, but randomizing the correlation values for all of the genes on the arrays or using 
the values from only the differentially expressed genes. For promoter binding site 
calculations, we calculated the number of promoters from differentially expressed genes 
with a given motif and compared them to the average number from a random selection of 
the same number of promoters from the genome. We assumed a normal distribution and a Z-
score less than 0.05 was called significant. Similar analysis was done for comparing genes 
with a haCNS and expression in human fetal brain. For microarray overlap comparisons, we 
included the number of differentially expressed genes as well as the total number of 
probesets on the microarrays for each comparison. We used a hypergeometric distribution 
test with 10,000 permutations to calculate the mean and standard deviation of the overlap. 
We assumed a normal distribution and a Z-score less than 0.05 was called significant.
Real-time PCR
RNA extraction and RT-PCR was performed as described6. Primer sequences are in 
Supplementary Table 10.
Site-directed mutagenesis
Mutagenesis of pCMV-Tag4a/FOXP26 was carried out using GeneTailor Site-Directed 
Mutagenesis System (Invitrogen) according the manufacturer’s instructions using the 
following primers: site 1 (asparagine to threonine): F-5′-
CCTCCTCGACTACCTCCTCCACAACTTCCAAAGC-3′; R-5′-
GGAGGAGGTAGTCGAGGAGGAATTGTTAGTA-3′; site 2 (serine to asparagine): F-5′-
ATGGACAGTCTTCAGTTCTAAACGCAAGACGAGA-3′; R-5′-
TAGAACTGAAGACTGTCCATTCACTATGGAA-3′. Mutagenesis was confirmed by 
both sequencing and mass spectrometry.
Weighted Gene Coexpression Network Analysis (WGCNA)
WGCNA was performed as previously described9,10. Briefly, genes were chosen for 
inclusion into the network based on their consistent presence on the array and high 
coefficient of variation, and they were clustered based on their topological overlap. For each 
module, singular value decomposition (X = UDV′) was performed, and the expression was 
re-calculated without the first principal component because it corresponded to cell line 
differences. The modules reported in this study were created using expression data with the 
first principal component removed, as it represented an experimental batch effect.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
FOXP2 and FOXP2chimp differentially regulate genes in SH-SY5Y cells. a) Schematic of 
human FOXP2 showing its major functional protein domains and the two amino acid 
changes in the mutant FOXP2chimp. b) Representative immunoblot for FLAG-tagged 
FOXP2 and FOXP2chimp stable overexpression in SH-SY5Y cells. c–e) Immunofluorescent 
staining of antibodies against FLAG epitope (green) and FOXP1 (red), and DAPI (blue) for 
nuclei. c) Vector cells demonstrate no FLAG expression, while both FOXP2 (d) and 
FOXP2chimp (e) expressing cells have FLAG-tagged FOXP2 in the cell nucleus. Scale bars 
are 5 microns. f) Subcellular fractionation followed by immunoblotting. g–h) Quantitative 
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RT-PCR of genes that were differentially expressed in cells expressing FOXP2 compared to 
FOXP2chimp. Asterisks indicate P≤0.05 and error bars are ± s.e.m. (two-tailed Student’s t-
test, n=3 or 4).
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Figure 2. 
FOXP2 and FOXP2chimp differentially transactivate target promoters independent of FOXP1 
or FOXP4 interaction. a) Immunoblotting for FLAG or FOXP1 following 
immunoprecipitation with either FLAG or FOXP1 Abs. b) Mass spectrometry results from 
SH-SY5Y or 293T cells overexpressing FOXP2 or FOXP2chimp. The first number indicates 
the number of spectra and the second is the number of unique peptides. c) Cell growth 
analysis does not show a significant difference in proliferation between cells expressing 
FOXP2 or FOXP2chimp over time (P≤0.05). Error bars are ± s.e.m. (two-tailed Student’s t-
test, n=3). d–e) Dual luciferase assays in 293T cells transiently transfected with promoter 
fragments driving luciferase and either FOXP2 or FOXP2chimp. Asterisks indicate P≤0.05 
and error bars are ± s.e.m. (two-tailed Student’s t-test, n=3–6).
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Figure 3. 
Visualization of one of the modules containing FOXP2 and FOXP2chimp differentially 
expressed genes. Five hundred pairs of genes with the greatest topological overlap are 
shown. Positive correlations are depicted in red and negative correlations are depicted in 
blue. The gene symbols for hub genes are accentuated in large bold text.
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